Samura B. Influence of atorvastatin therapy on biological markers and cardiovascular risk in patients with chronic lymphocytic leukemia in remission. Zaporozhye Medical Journal [Internet]. 2019Feb.8 [cited 2025Apr.29];21(1). Available from: https://zmj.zsmu.edu.ua/article/view/155793